Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MOSAIC: Mucosal Responses to FluMist in Healthy Adults
NCT07726862Phase 4Not yet recruiting
- Sponsor
- University of Alabama at Birmingham
- Start
- Dec 2026
- Primary completion
- Jun 2030
- Countries
- 1
01
Overview
A Phase 4 trial of influenza vaccine (trivalent, inactivated) or influenza vaccine (live, attenuated, intranasal) in influenza, sponsored by University of Alabama at Birmingham. Planned start Dec 2026; status: not yet recruiting.
02
Drugs
influenza vaccine (trivalent, inactivated) or influenza vaccine (live, attenuated, intranasal)
03
Conditions
influenza
Beyond the preview
Go deeper on NCT07726862.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07726862.